ArticleMolecular biology reports2025
Toxoplasma gondii soluble antigen (STAg) induces resistance against Mycobacterium tuberculosis in a human monocyte cell line via P2X7 receptor.
Article in Molecular biology reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
backgroundThe control of T. gondii in macrophages is mediated by the P2X7 receptor. The P2X7 receptor plays a crucial role in defense against Mycobacterium tuberculosis (M.tb), as well. Current study aimed to investigate the immunity induced by T. gondii soluble total antigen (STAg) against M.tb via P2X7R in human monocyte cell line.
methodsThe STAg was prepared from 1.6 × 10
resultsThe qReal-time PCR analysis showed overexpression of the ATG5 gene in P2X7R siRNA, scramble siRNA, and STAg/siRNA and ATG7 in THP-1 cell line treated by STAg groups, while they were suppressed in STAg/siRNA/ M.tb and STAg/ M.tb groups. The expression of ATG16 was significantly overexpressed in STAg group, while it was suppressed in treated wells by STAg/siRNA, STAg/siRNA/M.tb, STAg/M.tb, and M.tb. The number of entered M.tb in STAg/M.tb was significantly lower than M.tb group. The number of M.tb in P2X7R-knockdown THP-1 cells was significantly higher than scramble siRNA and STAg. In addition, the number of the bacteria in STAg/siRNA was significantly lower than P2X7R siRNA group.
conclusionOur study showed that sensing macrophages by T. gondii STAg may induce levels of immunity against M.tb. In addition, our findings support available data, indicating potential role of P2X7R in macrophage against T. gondii and M.tb.
Indexed as
Identifiers
40668463What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.